Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220.1 CHF | -0.63% | -0.77% | -9.98% |
Apr. 17 | Roche’s Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial | MT |
Apr. 17 | Roche: positive phase III results in MS | CF |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
220.1 CHF | -0.63% | -0.77% | 195B | ||
14.5 EUR | +0.46% | -0.68% | 30.29B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.98% | 195B | |
+28.79% | 673B | |
+24.81% | 551B | |
-7.64% | 348B | |
+15.00% | 317B | |
+5.99% | 288B | |
+2.47% | 210B | |
-0.02% | 204B | |
-11.71% | 145B | |
-8.32% | 142B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- ROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating